Overview
This study aims to determine the role of serum biomarkers and placental bloodflow in the comprehensive evaluation of the risk for spontaneous abortion
Description
To study the added value (if any) of combining serum markers, immunologic factors, and ultrasound parameters in comprehensively evaluating the risk for spontaneous abortion.
Eligibility
Inclusion Criteria:
- visualized fetal structures in utero & heart pulsations until 8th week of gestation
- normal THS/T4 levels
- no uterine malformations
- BMI < 27
- signed informed consent
Exclusion Criteria:
- fetal structures in utero & heart pulsations not visualized until the 8th week of gestation
- elevated THS/T4 levels
- uterine malformations
- BMI > 27